Skip to main content
Clinical Trials/ACTRN12621001327875
ACTRN12621001327875
Not yet recruiting
Phase 4

A prospective, randomised non-blinded pilot study to investigate the effect of oral tranexamic acid on the recovery time in patients undergoing primary total knee arthroplasty.

Wesley Medical Research0 sites80 target enrollmentSeptember 29, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Wesley Medical Research
Enrollment
80
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants of either sex scheduled to undergo a primary, unilateral Total Knee Arthroplasty.
  • 2\. Available for follow up at 6 months post\-surgery.
  • 3\. Willingness to provide written, informed consent.
  • 4\. Willingness to comply with the study.

Exclusion Criteria

  • 1\. Known allergy to TXA
  • 2, Acquired disturbances to colour vision
  • 3, Preoperative use of anticoagulants (within 5 days of surgery)
  • 4\. Fibrinolytic disorders requiring intraoperative fibrinolytics
  • 5\. Coagulopathy, history of arteriolar or venous thromboembolic disease
  • 6\. Pregnancy or breastfeeding
  • 7\. Haemoglobin \<10g/dL

Outcomes

Primary Outcomes

Not specified

Similar Trials